Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTate & Lyle Regulatory News (TATE)

Share Price Information for Tate & Lyle (TATE)

Share Price is delayed by 15 minutes
Get Live Data
505.00    4.50 (0.90%)
Bid:
505.00
Ask:
505.50
Spread: 0.50 (0.099%)
Market Cap: £2.23b
TATE Live PriceLast checked at - London Stock Exchange

Intraday Tate & Lyle Share Chart

20260526_TATE & LYLE_8.5 EPT RI_UK_MLI_replacement

1 Jun 2026 17:27

RNS Number : 5396G
Bank of America Merrill Lynch
01 June 2026
 

FORM 8.5 Replacement

 

 

The Form 8.5 Tate & Lyle Plc announcement released on 27/05/2026 under RNS 8946F has been amended.

 

Amendments are identified with an asterisk (*).

 

 

 

The full amended text is shown below

 

 

 

FORM 8.5 (EPT/RI)

 

PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY Rule 8.5 of the Takeover Code (the "Code")

 

1.

KEY INFORMATION

(a)

Name of exempt principal trader:

Merrill Lynch International

(b)

Name of offeror/offeree in relation to whoserelevant securities this form relates: Use a separate form for each offeror/offeree

TATE & LYLE PLC

(c)

Name of the party to the offer with which exempt principal trader is connected:

TATE & LYLE PLC

(d)

Date dealing undertaken:

26/05/2026

(e)

In addition to the company in 1(b) above, is theexempt principal trader making disclosures inrespect of any other party to this offer? If it is a cash offer or possible cash offer, state "N/A"

N/A

 

2.

DEALINGS BY THE EXEMPT PRINCIPAL TRADER

 

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(b), copy table 2(a), (b), (c) or (d) (as appropriate) for each additional classof relevant security dealt in.The currency of all prices and other monetary amounts should be stated.

 

(a)

Purchases and sales

Class of relevant security

Purchases/sales

Total number of securities

Highest price per unitpaid/received

Lowest price per unitpaid/received

29 1/6p ordinary

Purchase

249,057

5.065006 GBP

4.989000 GBP

29 1/6p ordinary

Sale

*157,177

5.100000 GBP

4.980000 GBP

 

(b)

Cash-settled derivative transactions

Class of relevant security

Product descriptione.g. CFD

Nature of dealinge.g. opening/closing a long/short position, increasing/reducing along/short position

Number of reference securities

Price per unit

29 1/6p ordinary

Swaps - Equity Swaps

Reducing a short position

426

5.028137 GBP

29 1/6p ordinary

Swaps - Equity Swaps

Reducing a long position

5,552

5.063159 GBP

29 1/6p ordinary

Swaps - Equity Swaps

Reducing a short position

1,489

5.028137 GBP

29 1/6p ordinary

Swaps - Equity Swaps

Increasing a long position

26,704

5.017535 GBP

29 1/6p ordinary

Swaps - Equity Swaps

Opening a Short position

10,000

5.000068 GBP

29 1/6p ordinary

Swaps - Equity Swaps

Opening a Short position

20,000

5.000068 GBP

29 1/6p ordinary

Swaps - Equity Swaps

Opening a Short position

3,000

5.000068 GBP

29 1/6p ordinary

Swaps - Equity Swaps

Increasing a short position

2,000

5.000068 GBP

29 1/6p ordinary

Swaps - Equity Swaps

Increasing a long position

1,865

5.017535 GBP

29 1/6p ordinary

Swaps - Equity Swaps

Reducing a short position

2,213

5.028137 GBP

29 1/6p ordinary

Swaps - Equity Swaps

Increasing a short position

2,213

5.060304 GBP

29 1/6p ordinary

Swaps - Equity Swaps

Opening a Short position

3,000

5.000068 GBP

29 1/6p ordinary

Swaps - Equity Swaps

Opening a Short position

11,500

5.000068 GBP

29 1/6p ordinary

Swaps - Equity Swaps

Reducing a long position

3,812

5.063159 GBP

29 1/6p ordinary

Swaps - Equity Swaps

Opening a Short position

4,500

5.000068 GBP

29 1/6p ordinary

Swaps - Equity Swaps

Opening a Short position

1,500

5.000068 GBP

29 1/6p ordinary

Swaps - Equity Swaps

Opening a Short position

44,500

5.000068 GBP

29 1/6p ordinary

Swaps - Equity Swaps

Increasing a long position

2,661

5.017535 GBP

29 1/6p ordinary

Swaps - Equity Swaps

Increasing a short position

2,348

4.994478 GBP

29 1/6p ordinary

Swaps - Equity Swaps

Increasing a short position

12,948

4.994478 GBP

29 1/6p ordinary

Swaps - Equity Swaps

Reducing a long position

1,126

5.008050 GBP

 

(c)

Stock-settled derivative transactions (including options)

(i)

Writing, selling, purchasing or varying

Class ofrelevant security

Product description e.g. call option

Writing, purchasing, selling, varying etc.

Number ofsecurities to which option relates

Exercise priceper unit

Typee.g. American, European etc.

Expiry date

Option money paid/ received per unit

N/A

N/A

N/A

N/A

N/A

N/A

N/A

N/A

 

(ii)

Exercise

Class of relevant security

Product descriptione.g. call option

Exercising/exercisedagainst

Number of securities

Exercise Price per unit

N/A

N/A

N/A

N/A

N/A

 

(d)

Other dealings (including subscribing for new securities)

Class of relevant security

Nature of dealinge.g. subscription, conversion

Details

Price per unit (if applicable)

N/A

N/A

N/A

N/A

 

3.

OTHER INFORMATION

 

(a)

Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the exempt principal trader making the disclosure and any party to the offer or any person acting in concert with a party to the offer: Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state "none"

None

 

(b)

Agreements, arrangements or understandings relating to options or derivatives

 

Details of any agreement, arrangement or understanding, formal or informal, between the exempt principal trader making the disclosure and any other person relating to: (i) the voting rights of any relevant securities under any option; or(ii) The voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced: If there are no such agreements, arrangements or understandings, state "none"

None

 

Date of disclosure:

*01/06/2026

Contact name:

Kamil Dziedzic

Telephone number:

+353 86 168 4821

 

Public disclosures under Rule 8 of the Code must be made to a Regulatory InformationService.The Panel's Market Surveillance Unit is available for consultation in relation to the Code'sdealing disclosure requirements on +44 (0)20 7638 0129.The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
FEREAKKFEALKEFA
Date   Source Headline
27th Mar 20262:00 pmRNSHolding(s) in Company
13th Mar 20264:00 pmRNSHolding(s) in Company
2nd Mar 20262:00 pmRNSHolding(s) in Company
26th Feb 20267:00 amRNSTrading Statement
23rd Feb 202610:00 amRNSHolding(s) in Company
17th Feb 202612:00 pmRNSHolding(s) in Company
21st Jan 20267:00 amRNSDirectorate change
15th Jan 20269:00 amRNSHolding(s) in Company
12th Jan 202610:00 amRNSHolding(s) in Company
7th Jan 20264:30 pmRNSDirector/PDMR Shareholding
7th Jan 20262:30 pmRNSBlock listing Interim Review
18th Dec 20252:00 pmRNSDirector/PDMR Shareholding
18th Dec 20252:00 pmRNSDirector/PDMR Shareholding
11th Dec 202512:18 pmRNSDirector/PDMR Shareholding
9th Dec 20259:00 amRNSHolding(s) in Company
27th Nov 202510:00 amRNSDirector/PDMR Shareholding
11th Nov 20254:30 pmRNSDirector/PDMR Shareholding
10th Nov 20252:40 pmRNSDirector Declaration
6th Nov 20257:00 amRNSHalf-year Financial Report
5th Nov 20252:15 pmRNSHolding(s) in Company
3rd Nov 20255:00 pmRNSHolding(s) in Company
29th Oct 20252:00 pmRNSHolding(s) in Company
23rd Oct 20254:15 pmRNSHolding(s) in Company
21st Oct 20253:30 pmRNSHolding(s) in Company
16th Oct 202512:00 pmRNSHolding(s) in Company
8th Oct 202512:00 pmRNSHolding(s) in Company
6th Oct 20254:30 pmRNSDirector/PDMR Shareholding
6th Oct 20254:00 pmRNSDirector/PDMR Shareholding
3rd Oct 20254:00 pmRNSDirector/PDMR Shareholding
3rd Oct 202510:00 amRNSDirector/PDMR Shareholding
1st Oct 20257:00 amRNSPre-close statement
2nd Sep 20258:00 amRNSTotal Voting Rights
11th Aug 20251:00 pmRNSDirector/PDMR Shareholding
5th Aug 20257:00 amRNSDirector/PDMR Shareholding
1st Aug 202511:00 amRNSTotal Voting Rights
24th Jul 20252:30 pmRNSResult of Annual General Meeting 2025
15th Jul 20251:00 pmRNSDirector/PDMR Shareholding
1st Jul 20253:30 pmRNSBlock listing Interim Review
1st Jul 20257:00 amRNSTate & Lyle Capital Markets Event
13th Jun 20253:00 pmRNSHolding(s) in Company
11th Jun 20254:30 pmRNSDirector/PDMR Shareholding
5th Jun 20252:30 pmRNSAnnual Financial Report and Notice of Meeting 2025
5th Jun 20252:00 pmRNSDirector/PDMR Shareholding
2nd Jun 202512:30 pmRNSTotal Voting Rights
28th May 202512:00 pmRNSDirector/PDMR Shareholding
27th May 202512:00 pmRNSDirector/PDMR Shareholding
23rd May 202510:00 amRNSDirector/PDMR Shareholding
22nd May 20257:00 amRNSFinal Results
14th May 20259:00 amRNSHolding(s) in Company
1st May 20253:00 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.